PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
123.00
+1.00 (0.82%)
Nov 5, 2026, 3:47 PM WIB

IDX:LABS Cash Flow Statement

Millions IDR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
8,73013,5072,9522,1902,834308.25
Depreciation & Amortization
2,35712,87912,3999,8929,2708,077
Other Operating Activities
1,179-3,494-29,032-26,909-27,151-29,016
Operating Cash Flow
12,26622,892-13,680-14,828-15,047-20,631
Operating Cash Flow Growth
-35.64%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-20,505-14,210-6,809-19,405-3,280-11,710
Sale of Property, Plant & Equipment
238.99331.02392.84240.235,1471,316
Cash Acquisitions
-10.42-10.42----
Sale (Purchase) of Intangibles
-357.29-357.29-438.35-6,147--
Investment in Securities
---4,404-2,400-
Other Investing Activities
----713.06-4,511-
Investing Cash Flow
-20,634-14,247-6,855-21,621-5,044-10,394

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-763.652,6512,759--
Long-Term Debt Issued
---18,86318,56333,968
Total Debt Issued
-112.36763.652,65121,62218,56333,968
Long-Term Debt Repaid
--10,797-11,336-547.47-44,647-303.61
Lease Payments
-641.25-1,282-581.83-547.47-559.86-303.61
Net Debt Issued (Repaid)
-5,470-10,034-8,68521,075-26,08533,665
Issuance of Common Stock
--71,40018,16335,405-
Other Financing Activities
---3,243---
Financing Cash Flow
-13,070-10,03459,47239,2389,32033,665

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-21,438-1,38938,9372,789-10,7702,640

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8,2398,681-20,490-34,233-18,327-32,341
Free Cash Flow Growth
------
Free Cash Flow Margin
-3.84%4.36%-13.88%-25.04%-19.65%-24.88%
Free Cash Flow Per Share
-2.112.20-5.19-14.54--
Levered Free Cash Flow
-20,1224,534-41,257-34,775-22,351-
Unlevered Free Cash Flow
-19,3445,313-39,357-33,430-21,380-
Free Cash Flow After Leases
-8,8817,399-21,072-34,780-18,887-32,644

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
317.021,2453,0412,1531,554112.31
Cash Income Tax Paid
4,52314,1269,7777,0664,4858,419